Physician profile
Michael R Moore
NPI 1164457800
$18,480.53
in general payments reported to CMS, 2019-2025
15 companies · $257 in 2025
The $257 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $482 · 2020: $13K · 2021: $3,417 · 2022: $212 · 2023: $668 · 2024: $76.11 · 2025: $257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,001.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,000.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $16,251.76 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $410.40 | 2019-2020 | |
| Alcon Vision LLC | $266.69 | 2021-2025 | Hydrus Microstent, Precision 1 |
| Glaukos Corporation | $234.54 | 2020-2023 | Kxl System (Not Refurbished) |
| Biotissue Holdings INC. | $208.87 | 2021-2023 | |
| Abbvie INC. | $173.44 | 2023-2024 | |
| Coopervision INC. | $158.41 | 2019-2023 | Myday Contact Lens |
| Rxsight INC | $125.00 | 2023 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Light Adjustable Lens (Rxlal) |
| Mallinckrodt Enterprises LLC | $123.31 | 2019 | |
| Sun Pharmaceutical Industries INC. | $122.42 | 2020 | |
| Horizon Therapeutics Plc | $119.56 | 2023 | Tepezza |
| Johnson & Johnson Vision Care, INC. | $107.29 | 2025 | |
| The Cameron-Ehlen Group, INC. | $77.07 | 2022 | |
| Abb Con-Cise Optical Group LLC | $64.21 | 2019 | |
| Bausch & Lomb Americas INC. | $37.56 | 2022-2023 | Infuse |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.